This study provides robust evidence supporting the use of SGLT2 inhibitors in heart failure with preserved ejection fraction. Long-term outcomes data would further strengthen these findings. - https://www.swissyp.com/pro/fisioterapia-bios/ The authors’ findings support expanded indications for bariatric surgery in metabolic disease. Multidisciplinary follow-up is mandatory. .